No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Express News | Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
CCORF Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $42
Canaccord Genuity Sticks to Its Buy Rating for Castle Biosciences (CSTL)
Wall Street Analysts Believe Castle Biosciences (CSTL) Could Rally 42.02%: Here's Is How to Trade
ABBV to Acquire Nimble Therapeutics to Strengthen Immunology Pipeline